According to latest research report published by MarketsandMarkets, the Eurpoe eClinical Solutions Market by Product (CDMS, eCOA, CTMS, RTSM, ETMF, Analytics, Safety), Delivery (Web-hosted, Licensed Enterprise, Cloud-based), End User (Pharma, Hospitals, CROs), Clinical Trial Phases (Phase I, II) & Region - Global Forecasts to 2027, is expected to grow at a CAGR of 13.3% from 2022 to 2027. The market is driven by the increasing adoption of eClinical solutions by pharmaceutical and biopharmaceutical companies, contract research organizations (CROs), and academic research institutes.
The increasing adoption of eClinical solutions is driven by the need to improve the efficiency and effectiveness of clinical trials. eClinical solutions can help to improve the accuracy and completeness of data collection, reduce the time and cost of clinical trials, and improve the safety and efficacy of new drugs and devices.
The eClinical solutions market in Europe is segmented by product, delivery mode, clinical trial phase, organization size, user device, end user, and region.
The key players in the eClinical solutions market in Europe include Oracle, IBM, Signant Health, Medrio, and ArisGlobal. These players are focusing on expanding their product portfolio, investing in research and development, and strengthening their partnerships to gain a competitive edge in the market.
Here are some of the key trends that are expected to drive the growth of the eClinical solutions market in Europe:
The eClinical solutions market in Europe is a highly competitive market. The key players in this market are continuously innovating and developing new products and services to meet the needs of their customers. The market is also expected to witness the entry of new players in the near future.
Here are some statistics on the eClinical solutions market in Europe:
These statistics show that the eClinical solutions market in Europe is a growing market with a lot of potential. The market is expected to be driven by the increasing adoption of cloud-based solutions, the growing focus on patient-centric clinical trials, and the increasing use of mobile devices in clinical trials.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]